Home > Back to Publisher > Report Information

Drug Eluting Coronary Stents Market Current Situation & Future Outlook

Medtech Reports
February 1, 2009
40 Pages - SKU: MEDT2107983

Abstract Table of Contents Related Reports

The market for drug eluting coronary stents is exhibiting clear evidence of recovery with average annual PCI volumes rising by 5% in the US and 4% in Europe. Average penetration rates are also rising in all markets.

Drug Eluting Coronary Stents Market - Current Situation & Future Outlook is a New 2009 Edition of Medtech Ventures' best selling report. The report offers a timely analysis of the latest happenings with market revenue and growth rates for main regions, up-to-date market shares for leading companies and brands and market forecasts to 2015.

With Drug Eluting Coronary Stents Market - Current Situation & Future Outlook, you’ll be able to:

Understand current market dynamics, competitor positions and market shares.
Assess market size and growth potential for these combined drug devices.
Monitor the competition’s marketed and in-development products.
Identify emerging technologies and the companies behind them.
Assess market potential and have access to forecasts till 2015.
Leverage your own technology and brain storm new business opportunities.
Investigate mergers, acquisitions and licensing possibilities

1. Executive Summary
2. Current Market Environment: 2.1 Coronary Artery Disease (CAD); 2.2 Coronary Artery Bypass & Graft (CABG); 2.3 Percutaneous Coronary Intervention (PCI); 2.4 Late Stage Thrombosis Controversy; 2.5 PCI Procedure Volumes; 2.6 Penetration Rate Trends
3. Current Market Situation: 3.1 Global Market for Drug Eluting Coronary Stents; 3.2 US Market for Drug Eluting Coronary Stents; 3.3 European Market for Drug Eluting Coronary Stents; 3.4 Asia Pacific Market for Drug Eluting Coronary Stents
4. Competitive Environment: 4.1 Leading Companies & Their Products; 4.2 Leading Companies Market Shares; 4.3 Competitive Situation
5. Future Outlook: 5.1 Market Growth Trends; 5.2 Market Forecast Scenarios; 5.3 Drug Eluting Coronary Stents Consensus Forecast
6. Technology Update: 6.1 Drug Eluting Stent Design; 6.2 Surface Coating Technology; 6.3 Drug Coated Stent Technology; 6.4 Drug Eluting Stent Technology; 6.5 Next Generation Drug Coated Stents; 6.6 Bioresorbable Stents; 6.7 Drug Eluting Balloons
7. Profiles of Main Companies: 7.1 Abbott Vascular; 7.2 Allvivo Vascular; 7.3 ART (Arterial Remodeling Technologies); 7.4 Biocompatibles; 7.5 Biosensors International; 7.6 Biotronik; 7.7 Blue Medical; 7.8 Boston Scientific; 7.9 Cook Medical; 7.10 Cordis - Johnson & Johnson; 5.11 Devax; 5.12 Endovasc; 5.13 Goodman; 5.14 InnoCore; 5.15 Medtronic; 5.16 MIV Therapeutics; 5.17 Reva Medical; 5.18 Stentys; 5.19 SurModics; 5.20 Terumo; 5.21 Translumina; 5.22 X-Cell Medical; 5.23 Xtent
List of Tables & Figures: 1. Global Drug Eluting Coronary Stents Market (2003 - 2008); 2. US Drug Eluting Coronary Stents Market (2003 - 2008); 3. European Drug Eluting Coronary Stents Market (2003 - 2008); 4. Asia-Pacific Drug Eluting Stents Market (2003 - 2008); 5. Leading DES Brands Market Share (2008 - Global); 6. Leading DES Brands Market Share (2008 - US); 7. Leading DES Brands Market Share (2008 - Europe); 8. Leading DES Brands Market Share (2008 - Asia-Pacific); 9. PCI Procedure Volume Trends; 10 DES Penetration Ratios; 11 Leading Companies & Their Products; 12. List of Potential Pharmacological Agents; 13. Products in Development and Near Commercialization; 14. Main Companies Market Shares; 15. Leading Companies Competitive Share Momentum Grid; 16 Linear Scenario Forecasts (2009 - 2015); 17. Drug Eluting Coronary Stents Market Forecast (2009 - 2015)

Drug Eluting Coronary Stents Market Current Situation & Future Outlook

Share this report

Other tasks

Research Assistance

Related Markets

Cardiovascular Reports

Free Alert Me service